AssayIndex
Reports by quarter

Reports submitted in 2024-Q3 · page 11

Nordanalyt Laboratories began contributing. Median purity for the quarter is 99.07 % area, n=464. Read the 2024-Q3 state-of-the-index report →

464 records12 pagesmedian on this page 99.23 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004521ExenatideHYBHYB-2407-J6692Janoshik2024-Q399.043.9599.8Buyer-sourced0PASS
AX-2024-004427SemaxGSPGSP-2404-P2784Janoshik2024-Q399.938.53—Buyer-sourced0PASS
AX-2024-005306TirzepatideBCHBCH-2404-N5218Janoshik2024-Q397.603.79104.0Laboratory-retained0PASS
AX-2024-005170N-Acetyl Semax AmideSGNSGN-2407-R9375PeptideMeter2024-Q398.647.75105.2Buyer-sourced2MARGINAL
AX-2024-004341EpitalonQSCQSC-2403-Y7501Nordanalyt2024-Q399.546.5497.4Buyer-sourced1MARGINAL
AX-2024-004163TirzepatideWWBWWB-2403-J3152Janoshik2024-Q398.964.01—Buyer-sourced0PASS
AX-2024-005267VIPBCHBCH-2405-R4888Janoshik2024-Q397.525.6890.8Buyer-sourced0PASS
AX-2024-005076SS-31 (Elamipretide)SSASSA-2408-G7111VendorInvestigate2024-Q397.686.25—Buyer-sourced0FAIL
AX-2024-005017IGF-1 LR3KPKP-2406-K5300Kestrel2024-Q396.986.56100.0Buyer-sourced0PASS
AX-2024-004592Enclomiphene citrateTFCTFC-2404-J9626Janoshik2024-Q399.443.91102.6Buyer-sourced0FAIL
AX-2024-004424SemaxGSPGSP-2404-P2784Janoshik2024-Q399.938.07100.9Laboratory-retained0PASS
AX-2024-004420SemaxGSPGSP-2404-P2784Medutest2024-Q399.937.9888.6Buyer-sourced1MARGINAL
AX-2024-004223LiraglutideWWBWWB-2406-R3462PeptideMeter2024-Q399.341.92—Buyer-sourced0PASS
AX-2024-005302TirzepatideBCHBCH-2404-N5218Janoshik2024-Q397.513.68101.5Buyer-sourced0PASS
AX-2024-005047RetatrutideSSASSA-2405-G6509Kestrel2024-Q398.686.66—Supplier-supplied1MARGINAL
AX-2024-005009SemaglutideKPKP-2405-C4939Janoshik2024-Q397.515.2196.5Buyer-sourced0PASS
AX-2024-004966SemaxMKMMKM-2407-Y4392PeptideMeter2024-Q399.479.95—Buyer-sourced0PASS
AX-2024-004723RetatrutideHomopeptideHOMO-2405-B3923PeptideMeter2024-Q397.935.54—Buyer-sourced0PASS
AX-2024-004543HexarelinHYBHYB-2407-N7367PeptideMeter2024-Q399.935.1995.3Buyer-sourced0PASS
AX-2024-004405PT-141 (Bremelanotide)ASYASY-{CAT}-2723Janoshik2024-Q399.624.11—Buyer-sourced0PASS
AX-2024-004339EpitalonQSCQSC-2403-Y7501Medutest2024-Q399.936.33100.2Buyer-sourced1MARGINAL
AX-2024-005231GHRP-2WXTWXT-2404-N2537Janoshik2024-Q398.266.05—Buyer-sourced0FAIL
AX-2024-004298IGF-1 LR3QSCQSC-2405-U6435PeptideMeter2024-Q399.125.57104.0Buyer-sourced1MARGINAL
AX-2024-004221LiraglutideWWBWWB-2406-R3462Janoshik2024-Q399.582.2396.0Buyer-sourced0PASS
AX-2024-005305TirzepatideBCHBCH-2404-N5218Medutest2024-Q398.443.7092.6Supplier-supplied1MARGINAL
AX-2024-004959PT-141 (Bremelanotide)MKMMKM-2404-E3617Kestrel2024-Q399.934.07—Buyer-sourced1FAIL
AX-2024-004511RetatrutideHYBHYB-2407-W6594Janoshik2024-Q398.235.22102.5Laboratory-retained0PASS
AX-2024-004400PT-141 (Bremelanotide)ASYASY-{CAT}-2723PeptideMeter2024-Q399.394.81—Buyer-sourced0PASS
AX-2024-004334EpitalonQSCQSC-2403-Y7501Janoshik2024-Q399.836.8094.0Buyer-sourced1FAIL
AX-2024-005271VIPBCHBCH-2405-R4888VendorInvestigate2024-Q396.375.0493.4Buyer-sourced0FAIL
AX-2024-005268VIPBCHBCH-2405-R4888Kestrel2024-Q397.704.42106.9Buyer-sourced0PASS
AX-2024-004597Enclomiphene citrateTFCTFC-2404-J9626VendorInvestigate2024-Q398.863.89—Buyer-sourced0FAIL
AX-2024-004166TirzepatideWWBWWB-2403-J3152VendorInvestigate2024-Q398.493.43—Buyer-sourced0PASS
AX-2024-004243TB-500QYBQYB-2407-J3967VendorInvestigate2024-Q399.903.96—Buyer-sourced0PASS
AX-2024-004333EpitalonQSCQSC-2403-Y7501Kestrel2024-Q399.935.87106.9Buyer-sourced1MARGINAL
AX-2024-005250SelankWXTWXT-2406-W3910Kestrel2024-Q399.379.27—Buyer-sourced1FAIL
AX-2024-005005SemaglutideKPKP-2405-C4939Janoshik2024-Q398.225.17—Buyer-sourced0PASS
AX-2024-004868IpamorelinERPERP-2406-F9295Nordanalyt2024-Q399.413.97—Buyer-sourced0PASS
AX-2024-004709OxytocinHomopeptideHOMO-2405-U3389Janoshik2024-Q399.935.12—Buyer-sourced0PASS
AX-2024-004367SermorelinFGPFGP-2406-D8645Janoshik2024-Q399.373.47103.2Buyer-sourced1MARGINAL